Drug Week
Susan Hasty, Publisher
Table of Contents . . . August 30th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Alzheimer Disease - Axura demonstrates benefits in two studies
Vascular Dementia - Promising drug in treatment of stroke-induced dementia
Anemia - FDA approves Aranesp for anemia associated with chemotherapy
Hypertension - FDA committee suggests inclusion of comparative data in prescribing information
Menopause - Red clover may be an alternative to hormone replacement therapy
Alpha-1 Antitrypsin Deficiency - Orphan drug designation granted for ETX-100
Antibiotic - Generic form of Augmentin launched
Hepatitis C - FDA grants priority review for PEGASYS-Ribavirin combination
Hypertension - New formulation of Lotrel, 10/20 mg, now available
Narcolepsy - Orphan Medical announces FDA approval of Xyrem
Non-Small Cell Lung Cancer - Angiostatin phase II clinical trial underway
Pediatric Depression - Six-month extension granted on Celexa
Pediatric HIV/AIDS - Protease inhibitor multitherapy has limited efficacy for infants
Sedation - European phase II clinical trial of Aquavan injection initiated
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
